CoChat

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

Open access

The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index.

Abstract

Aims: As the potential impact of statins on cognitive decline and dementia is still debated, we conducted a meta-analysis of observational studies to examine the effect of statin use on the risk of Alzheimer’s disease (AD) and dementia. Methods and results: PubMed, Cochrane, and EMBASE were searched since inception to January 2021. Inclusion criteria were: (i) cohort or case–control studies; (ii) statin users compared to non-users; and (iii) AD and/or dementia risk as outcome. Estimates from original studies were pooled using restricted maximum-likelihood random-effect model. Measure of effects were reported as odds ratio (OR) and 95% confidence intervals (CIs). In the pooled analyses, statins were associated with a decreased risk of dementia [36 studies, OR 0.80 (CI 0.75–0.86)] and of AD [21 studies, OR 0.68 (CI 0.56–0.81)]. In the stratified analysis by sex, no difference was observed in the risk reduction of dementia between men [OR 0.86 (CI 0.81–0.92)] and women [OR 0.86 (CI 0.81–0.92)]. Similar risks were observed for lipophilic and hydrophilic statins for both dementia and AD, while high-potency statins showed a 20% reduction of dementia risk compared with a 16% risk reduction associated with low-potency statins, suggesting a greater efficacy of the former, although a borderline statistical significance (P = 0.05) for the heterogeneity between estimates. Conclusion: These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjpc/zwab208

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC · From the PDF
Figure 1 PRISMA flow diagram of literature search and study selection. Adapted from Moher et al . 100
Figure 1 PRISMA flow diagram of literature search and study selection. Adapted from Moher et al . 100CC-BY-NC · From the PDF
Figure 2 Meta-analysis of statin use and dementia risk.
Figure 2 Meta-analysis of statin use and dementia risk.CC-BY-NC · From the PDF
Figure 3 Meta-analysis of statin use and risk of Alzheimer's disease.
Figure 3 Meta-analysis of statin use and risk of Alzheimer's disease.CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 96 references

Research works printed but not linked: 2

  1. Zhou, 2007, Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis, Dement Geriatr Cogn Disord, 23, 194, 10.1159/000099037 · DOI · Paper page
  2. 1992, The ICD-10 Classification of Mental and Behavioural Disorders: clinical Descriptions and Diagnostic Guidelines

Cited by

See all 197

Metadata

Authors
Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M.
Affiliations
  • University of Milan (IT)
  • MultiMedica (IT)
  • Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, Via Balzaretti 9, 20133 Milan, Italy
  • University of Padua (IT)
Corresponding author
Casula, Manuela
Venue
European Journal of Preventive Cardiology
Published
2021-12-06
Volume
29
Issue
5
Pages
804-814
ISSN
  • 2047-4873 (ISSN-L)
  • 2047-4881
OpenAlex
W4200013341
Cited by
197
References
97
Citations by year
2026: 43 · 2025: 52 · 2024: 59 · 2023: 25 · 2022: 17 · 2021: 1
FWCI
4.61
Type
journal article
Language
en
Open access
Locations
  • European Journal of Preventive Cardiology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc)
Funders
  • Ministry of Health-IRCCS MultiMedica (GR-2016-02361198, GR-2011-02346974)
  • Fondazione SISA
  • Fondazione Cariplo (2015-0524, 2015-0564)
  • H2020 REPROGRAM (PHC-03-2015/667837-2)
  • ERANET (ER-2017-2364981, PRIN 2017H5F943)
  • SISA Lombardia and Fondazione SISA
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
statins, dementia, Alzheimer's disease, cognitive decline, neuroprotection, statin potency, sex differences, drug safety
MeSH terms
Alzheimer Disease, Dementia, Female, Humans, Male, Odds Ratio, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies. https://app.cochat.ai/papers/10.1093/eurjpc/zwab208
The paper
Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M. (2022). Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwab208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.